Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22547592 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Small Cell Lung Cancer Trial With IpiliMUmab in LImited Disease
Conditions: Limited Stage Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention: Drug: Ipilimumab

Indicates status has not been verified in more than two years